Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines
Stefano Omboni,1 Ettore Malacco,2 Jean-Michel Mallion,3 Massimo Volpe4,5 1Clinical Research Unit, Italian Institute of Telemedicine, Solbiate Arno, Varese, Italy; 2Department of Internal Medicine, Ospedale L Sacco, University of Milan, Milan, Italy; 3Cardiology and Arterial Hypertension, CHU de Gre...
Guardado en:
Autores principales: | Omboni S, Malacco E, Mallion JM, Volpe M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b08462ba962f451b96580b3be2149adc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum]
por: Omboni S, et al.
Publicado: (2017) -
ACID- ALKALI DEGRADATION STUDY ON OLMESARTAN MEDOXOMIL AND DEVELOPMENT OF VALIDATED STABILITY-INDICATING CHROMATOGRAPHIC METHODS
por: MOUSSA,BAHIA, et al.
Publicado: (2010) -
Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: in vitro, ex vivo, and in vivo evaluation
por: Albash R, et al.
Publicado: (2019) -
Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: in-vitro characterization, ex-vivo permeation and in-vivo assessment
por: Albash R, et al.
Publicado: (2019) -
A STABILITY INDICATING HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF VALSARTAN AND RAMIPRIL IN BINARY COMBINATION
por: LAKSHMI,K. S, et al.
Publicado: (2010)